Trials that use: Fisher exact test
New to this method? Read the tutorial →
4,441 results
- Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Aprepitant for PONV Prophylaxis in Outpatient Plastic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00659945).
- APROPOSIndependent statistical analysis of A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01907269).
- AQUACEL® Ag+ Extra™ and Cutimed™ Sorbact® Dressing in the Management of Venous Leg Ulcers Over a 12-week Period: Complete Statistical AnalysisIndependent statistical analysis of AQUACEL® Ag+ Extra™ and Cutimed™ Sorbact® Dressing in the Management of Venous Leg Ulcers Over a 12-week Period: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ARC001Independent statistical analysis of Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ARCADIANIndependent statistical analysis of Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04648033).
- ARDAIndependent statistical analysis of A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy: primary endpoint…
- ARESTIndependent statistical analysis of Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ARICAIndependent statistical analysis of AdheRence to Inhaled Corticosteroids in Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03769519).
- Arimoclomol in Amyotropic Lateral Sclerosis – Open Label Extension Trial: Complete Statistical AnalysisIndependent statistical analysis of Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03836716).
- ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection: Complete Statistical AnalysisIndependent statistical analysis of ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ARMIndependent statistical analysis of CoolSculpting the Upper Arm Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02669329).
- Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…
- ARMOURIndependent statistical analysis of Proximal Protection With The Mo.Ma Device During Carotid Stenting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00744523).
- ARMSIndependent statistical analysis of Automated Reinforcement Management System (ARMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04656925).
- ARRIVEIndependent statistical analysis of A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease: primary endpoint results, effect estimate with confidence interval,…
- ARRIVE USIndependent statistical analysis of Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ARRIVE- EUIndependent statistical analysis of Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ARTISTSIndependent statistical analysis of Evaluation of Safety and Tolerability of Long-term TEV-50717 (Deutetrabenazine) for Treatment of Tourette Syndrome in Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ARTISTYKIndependent statistical analysis of A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting: primary endpoint results, effect estimate with confidence…
- ARTSS-2Independent statistical analysis of Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- AS900672-Enriched in Ovulation Induction: Complete Statistical AnalysisIndependent statistical analysis of AS900672-Enriched in Ovulation Induction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553514).
- ASCEND-PIndependent statistical analysis of Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I: Complete Statistical AnalysisIndependent statistical analysis of Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I: primary endpoint results, effect estimate with confidence interval, sample-size…
- Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II: Complete Statistical AnalysisIndependent statistical analysis of Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-913 in Subjects With MPS II: primary endpoint results, effect estimate with confidence interval, sample-size…
- Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients: Complete Statistical AnalysisIndependent statistical analysis of Ascending Multiple-Doses of Erenumab (AMG 334) in Healthy Adults and in Migraine Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients: Complete Statistical AnalysisIndependent statistical analysis of Ascending Single Doses of Erenumab (AMG 334) in Healthy Adults and Migraine Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ASCENTIndependent statistical analysis of A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ASIA MRI ICDIndependent statistical analysis of A Post-market Clinical Evaluation of St. Jude Medical™ MR Conditional ICD System on Patients Undergoing Magnetic Resonance Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- ASPIRINIndependent statistical analysis of Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02409680).
- Aspirin and Enoxaparin for VTE in Trauma: Complete Statistical AnalysisIndependent statistical analysis of Aspirin and Enoxaparin for VTE in Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02396732).
- Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation: Complete Statistical AnalysisIndependent statistical analysis of Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ASSENTIndependent statistical analysis of Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals’ Pandemic Influenza Vaccine (GSK1562902A) in Adults: Complete Statistical AnalysisIndependent statistical analysis of Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule: Complete Statistical AnalysisIndependent statistical analysis of Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule: primary endpoint results, effect estimate with confidence interval, sample-size…
- Assessing and Improving Patient Knowledge About Keloid Scars (Keloids): Complete Statistical AnalysisIndependent statistical analysis of Assessing and Improving Patient Knowledge About Keloid Scars (Keloids): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01176877).
- Assessing Supported Employment With Veterans With Felony Convictions and Mental Illness or Substance Abuse: Complete Statistical AnalysisIndependent statistical analysis of Assessing Supported Employment With Veterans With Felony Convictions and Mental Illness or Substance Abuse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Assessing the Effect of a Blood-based Colorectal Cancer Screening Test on Screening Adherence and Colonoscopy Completion: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Effect of a Blood-based Colorectal Cancer Screening Test on Screening Adherence and Colonoscopy Completion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca: Complete Statistical AnalysisIndependent statistical analysis of Assessing the Efficacy and Safety of IV Vitamin C in Combination With Standard Chemotherapy for Pancreatic Ca: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size…
- Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101): Complete Statistical AnalysisIndependent statistical analysis of Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia: Complete Statistical AnalysisIndependent statistical analysis of Assessment and Treatment of Social Skills Deficits in Individuals With Social Phobia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Assessment of a New “Boosting” Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Assessment of a New "Boosting" Strategy for HIV Pre-exposure Prophylaxis in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics: Complete Statistical AnalysisIndependent statistical analysis of Assessment of Coronary Flow Reserve in Heart Failure Patients After Ultrafiltration Versus Diuretics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assessment of KAN-101 in Celiac Disease (ACeD): Complete Statistical AnalysisIndependent statistical analysis of Assessment of KAN-101 in Celiac Disease (ACeD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04248855).
- Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO): Complete Statistical AnalysisIndependent statistical analysis of Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE): Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties: Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Safety and the Performance of the SAGITTA EVL R Stems in Hip Arthroplasties: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents: Complete Statistical AnalysisIndependent statistical analysis of Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying…
- ASSISTIndependent statistical analysis of AsseSSing Impact in pSoriatic Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05171270).